ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,100,000 | +122.2% | 249,231 | +32.0% | 0.33% | +103.1% |
| Q2 2016 | $1,395,000 | -59.1% | 188,768 | -67.7% | 0.16% | -82.6% |
| Q3 2015 | $3,410,000 | +3028.4% | 583,841 | +3570.8% | 0.94% | +1540.4% |
| Q4 2014 | $109,000 | -36.3% | 15,905 | -40.7% | 0.06% | +18.8% |
| Q2 2014 | $171,000 | +9.6% | 26,800 | +38.9% | 0.05% | -5.9% |
| Q1 2014 | $156,000 | – | 19,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |